Understanding changing brands of biologics
The What you need to know about changing brands of biologics consumer counselling tool is designed to help health professionals…
Andexanet alfa
CATAG created this document to facilitate and support the translation of best available evidence into practice regarding the potential use…
Understanding high-cost medicines in public hospitals
The High-cost medicines in public hospitals consumer counselling tool is designed to help health professionals talk with consumers about the…
Navigating high-cost medicines: summary of the Guiding Principles for the governance of high-cost medicines in Australian hospitals
Navigating high-cost medicines: summary of the Guiding Principles for the governance of high-cost medicines in Australian hospitals Catherine L. Hill,…
Navigating High-Cost Medicines
Promoting consistent, evidence based use of high cost medicines in a fiscally and equitable responsible manner. Presented at Health Technology…
Navigating high-cost medicines
These Guiding Principles provide a principles based high level framework outlining national objectives to assist medicines governance committees, including Medicines…
Biologics and biosimilars best practice
These Guiding Principles provide a national approach to the governance of biologics and their biosimilars. They assist those responsible for…
Assessment and evaluation of high cost medicines in Australian public hospitals
Poster presentation at SHPA Medicines Management Conference 2015 aiming to describe the decision-making process for access to High Cost Medicines…
Overseeing Biosimilar Use: Guiding Principles for the governance of biological and biosimilar medicines in Australian hospitals
Poster presentation at SHPA Medicines Management Conference 2015. This poster aims to provide guidance for good governance and decision-making in…